Literature DB >> 22398714

Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Gisela Enders1, Anja Daiminger, Lisa Lindemann, Frank Knotek, Ursula Bäder, Simone Exler, Martin Enders.   

Abstract

In Germany, studies on the IgG seroprevalence in pregnancy and in women of childbearing age are rare. Therefore, we retrospectively evaluated the CMV IgG seropositive rate in 40,324 pregnant women as well as in 31,093 female and male bone marrow donors over 15 consecutive years (1996-2010). Furthermore, the result of a study conducted in 1999 investigating 1,305 healthy adolescents with known ethnicity was included. The overall CMV IgG seroprevalence in pregnant women (15-50 years) was 42.3%. Age-dependent analysis revealed a significantly higher seropositive rate (55.6%) in young women (15-25 years) than in those aged 26-40 years (37-42%) and in women older than 40 years (48.3%). Over the study period of 15 years, the rate of seroprevalence in pregnant women declined significantly (χ(2) test < 0.01) from 44.3% in the first interval period (1996-2000), to 42.8% (2001-2005) and to 40.9% (2006-2010). The most influencing factor on CMV seropositivity appeared to be the socioeconomic status (SES), which we characterized by type of health insurance: Seroprevalence in women with low, middle and upper SES was 91.8, 46.9 and 33.7%, respectively. Female bone marrow donors of childbearing age (15-45 years) showed a significantly higher seropositive rate of 36.5% than age-matched male donors (28.6%). In adolescents aged 13-16 years, no gender-specific differences were recognized. Concerning ethnicity, youngsters with German descent had a significantly lower seroprevalence (29.9%) than those with non-German descent (67.4%).

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22398714     DOI: 10.1007/s00430-012-0232-7

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  28 in total

1.  Continuous cytomegalovirus seroconversion in a large group of healthy blood donors.

Authors:  M Hecker; D Qiu; K Marquardt; G Bein; H Hackstein
Journal:  Vox Sang       Date:  2004-01       Impact factor: 2.144

2.  [Incidence of congenital infections].

Authors:  K Friese; M Beichert; H Hof; W Weikel; D Falke; R Sickinger; F Melchert
Journal:  Geburtshilfe Frauenheilkd       Date:  1991-11       Impact factor: 2.915

3.  The incidence of congenital cytomegalovirus infections in The Netherlands.

Authors:  Michael A Gaytant; Jochem M D Galama; Ben A Semmekrot; Willem J G Melchers; Jan M M Sporken; Herman P Oosterbaan; Peter A van Dop; Aad Huisman; Hans M W M Merkus; Eric A P Steegers
Journal:  J Med Virol       Date:  2005-05       Impact factor: 2.327

4.  Passive immunization during pregnancy for congenital cytomegalovirus infection.

Authors:  Giovanni Nigro; Stuart P Adler; Renato La Torre; Al M Best
Journal:  N Engl J Med       Date:  2005-09-29       Impact factor: 91.245

5.  Maternal antibodies against cytomegalovirus in pregnancy and the risk of fetal death and low birth weight.

Authors:  Anne Eskild; Pål A Jenum; Anne-Lise Bruu
Journal:  Acta Obstet Gynecol Scand       Date:  2005-11       Impact factor: 3.636

6.  Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in western region of Turkey.

Authors:  Gulden Sonmez Tamer; Deyrim Dundar; Eray Caliskan
Journal:  Clin Invest Med       Date:  2009-02-01       Impact factor: 0.825

7.  Prevalence of cytomegalovirus infection in Italy.

Authors:  D de Mattia; T Stroffolini; S Arista; D Pistoia; A Giammanco; M Maggio; M Chiaramonte; M E Moschen; I Mura; G Rigo
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

8.  Cytomegalovirus prevalence in pregnant women: the influence of parity.

Authors:  P A Tookey; A E Ades; C S Peckham
Journal:  Arch Dis Child       Date:  1992-07       Impact factor: 3.791

Review 9.  Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant.

Authors:  Robert F Pass
Journal:  J Clin Virol       Date:  2009-07-31       Impact factor: 3.168

10.  Seroprevalence of Toxoplasma gondii, rubella and cytomegalovirus among pregnant women in southern Turkey.

Authors:  Sabahattin Ocak; Sahin Zeteroglu; Cahit Ozer; Kenan Dolapcioglu; Arif Gungoren
Journal:  Scand J Infect Dis       Date:  2007
View more
  29 in total

Review 1.  Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature.

Authors:  Vera Seidel; Cornelia Feiterna-Sperling; Jan-Peter Siedentopf; Jörg Hofmann; Wolfgang Henrich; Christoph Bührer; Katharina Weizsäcker
Journal:  Med Microbiol Immunol       Date:  2017-07-21       Impact factor: 3.402

2.  The risk of cytomegalovirus infection in daycare workers: a systematic review and meta-analysis.

Authors:  Karla Romero Starke; Marlen Kofahl; Alice Freiberg; Melanie Schubert; Mascha Luisa Groß; Stefanie Schmauder; Janice Hegewald; Daniel Kämpf; Johanna Stranzinger; Albert Nienhaus; Andreas Seidler
Journal:  Int Arch Occup Environ Health       Date:  2019-07-29       Impact factor: 3.015

Review 3.  Preventing vertical virus infections: the role of serologic screening of pregnant women.

Authors:  Annemarie Berger; Hans Wilhelm Doerr
Journal:  Med Microbiol Immunol       Date:  2018-07-03       Impact factor: 3.402

Review 4.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

Review 5.  Primary Human Cytomegalovirus (HCMV) Infection in Pregnancy.

Authors:  Horst Buxmann; Klaus Hamprecht; Matthias Meyer-Wittkopf; Klaus Friese
Journal:  Dtsch Arztebl Int       Date:  2017-01-27       Impact factor: 5.594

6.  Comparison of six real-time PCR assays for qualitative detection of cytomegalovirus in clinical specimens.

Authors:  M J Binnicker; M E Espy
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

7.  Infection status of human parvovirus B19, cytomegalovirus and herpes simplex Virus-1/2 in women with first-trimester spontaneous abortions in Chongqing, China.

Authors:  Ya-Ling Gao; Zhan Gao; Miao He; Pu Liao
Journal:  Virol J       Date:  2018-04-23       Impact factor: 4.099

8.  Seroepidemiology of cytomegalovirus infections in Croatia.

Authors:  Tatjana Vilibic-Cavlek; Branko Kolaric; Natasa Beader; Izabela Vrtar; Irena Tabain; Gordana Mlinaric-Galinovic
Journal:  Wien Klin Wochenschr       Date:  2016-09-06       Impact factor: 1.704

9.  CMV infection in a cohort of HIV-exposed infants born to mothers receiving antiretroviral therapy during pregnancy and breastfeeding.

Authors:  Maria Franca Pirillo; Giuseppe Liotta; Mauro Andreotti; Haswel Jere; Jean-Baptiste Sagno; Paola Scarcella; Sandro Mancinelli; Ersilia Buonomo; Roberta Amici; Maria Cristina Marazzi; Stefano Vella; Leonardo Palombi; Marina Giuliano
Journal:  Med Microbiol Immunol       Date:  2016-09-15       Impact factor: 3.402

10.  Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.

Authors:  A Reitter; H Buxmann; A E Haberl; R Schlösser; M Kreibich; O T Keppler; A Berger
Journal:  Med Microbiol Immunol       Date:  2015-07-09       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.